Table 3.
Clinical data from baseline to day 90
Scale | Baseline score | Day 90 score |
---|---|---|
NIHSS--all patients (n=15 at baseline, n=12 at d90) |
10 (6–19) | 2 (0–6) |
Barthel Index (n=11 at baseline, n=12 at d90) |
25 (0–100) | 95 (70–100) |
Arm Fugl-Meyer Motor Scale (n=12 at baseline, n=12 at d90; normal score= 66) |
32 (2–65) | 62 (4–66) |
Leg Fugl-Meyer Motor Scale (n=10 at baseline, n=12 at d90; normal score= 34) |
20 (3–34) | 32 (20–34) |
Boston Naming Test (n=13 at baseline, n=12 at d90; normal=10) |
2 (0–10) | 8 (2–10) |
Line Cancellation Test (n=8 at baseline, n=12 at d90; normal = 100%) |
96 (20–100) % | 100 (87–100) % |
Action Research Arm Test (n=9 at baseline, n=11 at d90; normal=57) |
23 (0–57) | 57 (0–57) |
Trailmaking A, # connected (n=7 at baseline, n=12 at d90; normal=25) |
8 (0–25) | 25 (12–25) |
Trailmaking B, # connected (n=5 at baseline, n=11 at d90; normal=25) |
3 (0–11) | 22 (6–25) |
The total number of testable subjects was 15 at baseline and 12 at day 90. Data are presented when scoring could be completed. Values are median (range).
Baseline scores were tested < 48 hours after stroke onset, and prior to B-E therapy, except for the Barthel Index, for which baseline testing was done 6 days after study entry.
Note that 8 of 12 subjects had day 90 Barthel Index score ≥95.
Review of the line cancellation test indicated left hemineglect in 4 of 8 subjects at baseline, and in 1 of 12 subjects at day 90.
For the Geriatric Depression Scale at day 90 (n=12), the median score was 5 (range 0–12), with five patients having a score of 6 or greater, which is suggestive of depression.